DLX4 is associated with orofacial clefting and abnormal jaw development. Read more about DLX4 is associated with orofacial clefting and abnormal jaw development.
The active Hsc70/tau complex can be exploited to enhance tau turnover without damaging microtubule dynamics. Read more about The active Hsc70/tau complex can be exploited to enhance tau turnover without damaging microtubule dynamics.
Fine-mapping identifies two additional breast cancer susceptibility loci at 9q31.2. Read more about Fine-mapping identifies two additional breast cancer susceptibility loci at 9q31.2.
SRY interference of normal regulation of the RET gene suggests a potential role of the Y-chromosome gene in sexual dimorphism in Hirschsprung disease. Read more about SRY interference of normal regulation of the RET gene suggests a potential role of the Y-chromosome gene in sexual dimorphism in Hirschsprung disease.
Identification and characterization of novel associations in the CASP8/ALS2CR12 region on chromosome 2 with breast cancer risk. Read more about Identification and characterization of novel associations in the CASP8/ALS2CR12 region on chromosome 2 with breast cancer risk.
Genomic analysis of fibrolamellar hepatocellular carcinoma. Read more about Genomic analysis of fibrolamellar hepatocellular carcinoma.
Genome-wide association and admixture analysis of glaucoma in the Women's Health Initiative. Read more about Genome-wide association and admixture analysis of glaucoma in the Women's Health Initiative.
Imputation and subset-based association analysis across different cancer types identifies multiple independent risk loci in the TERT-CLPTM1L region on chromosome 5p15.33. Read more about Imputation and subset-based association analysis across different cancer types identifies multiple independent risk loci in the TERT-CLPTM1L region on chromosome 5p15.33.
Common non-synonymous SNPs associated with breast cancer susceptibility: findings from the Breast Cancer Association Consortium. Read more about Common non-synonymous SNPs associated with breast cancer susceptibility: findings from the Breast Cancer Association Consortium.
Genetic variation in mitotic regulatory pathway genes is associated with breast tumor grade. Read more about Genetic variation in mitotic regulatory pathway genes is associated with breast tumor grade.